Results 121 to 130 of about 53,775 (260)

A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT Radiation therapy (RT) has emerged as a promising non‐surgical approach for treating canine adrenal tumours. This multi‐institutional, retrospective study describes clinical outcomes for 21 dogs having been prescribed a course of hypofractionated image‐guided intensity‐modulated RT (IMRT) entailing delivery of 25–35 Gy total in 5 fractions ...
Yen‐Hao Erik Lai   +4 more
wiley   +1 more source

Retrospective Analysis of Survival and Adverse Effects Associated With Stereotactic Body Radiation Therapy in 12 Dogs With Hepatocellular Carcinoma

open access: yesVeterinary and Comparative Oncology, EarlyView.
ABSTRACT This retrospective analysis evaluated 12 dogs with hepatocellular carcinoma (HCC) who received stereotactic body radiation therapy (SBRT). Dogs received between 6 and 25 Grey (Gy) per fraction for 1–5 fractions for a total dose of 13–30 Gy. Eleven patients (92%) experienced acute adverse effects (AE), with the majority being VRTOG grade 2–3 ...
Victoria Lee Newberry   +3 more
wiley   +1 more source

Laparoscopic stapled partial cystectomy with intraoperative cystourethroscopy for urothelial carcinoma in two dogs

open access: yesVeterinary Surgery, EarlyView.
Abstract Objective To describe the procedure and short‐term outcomes of two dogs that underwent laparoscopic stapled partial cystectomy with intraoperative cystoscopy for excision of solitary, non‐trigonal, urothelial carcinoma lesions. Animals A 12‐year‐old female spayed mixed breed and a 13‐year‐old female spayed Siberian Husky.
Maureen A. Griffin   +2 more
wiley   +1 more source

Criteria for selecting children for speech therapy in the public schools [PDF]

open access: yes, 1961
Thesis (Ed.M.)--Boston ...
Driben, Margo, Rubin, Lillian B.
core  

Petropower in Law‐Enforcement Advertising at Super Bowl LIX

open access: yesThe Geographical Journal, Volume 192, Issue 2, June 2026.
Short Abstract This paper examines a recruitment commercial from the Super Bowl on 9 February 2025 in terms of its spectacularisation of petroleum's abiding yet volatile influence. The minute‐long piece on behalf of federal law enforcement indicates how the workings of power in the United States of America are entangled with the ubiquity of oil ...
Daniel A. Finch‐Race, Pancho Lewis
wiley   +1 more source

Laryngeal amyloidosis: An uncommon cause of dysphonia [PDF]

open access: yes, 2014
Introduction: Amyloidosis is used to describe a range of disorders deined by extracellular deposition of abnormal protein ibrils. The larynx is the most common site of localized amyloidosis in the head and neck region and constitutes less than 1% of ...
González Andrade, Baltazar   +5 more
core  

The Voice of Cantú: Lower Voice Pitch Is a New Phenotypic Feature of Cantú Syndrome

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 5, Page 1062-1068, May 2026.
ABSTRACT Cantú syndrome (CS) is a rare genetic condition caused by pathogenic variants in either ABCC9 or KCNJ8, leading to gain‐of‐function of KATP‐channels. The main clinical features are hypertrichosis and cardiovascular abnormalities. This study investigates the voice characteristics in individuals with CS, an aspect that has received little ...
Lotte Kleinendorst   +4 more
wiley   +1 more source

External laryngeal trauma

open access: yesSwiss Medical Weekly, 2003
MZ Ozuer   +5 more
doaj   +1 more source

Vocal fold cyst: A narrative review

open access: yesJournal of Clinical and Scientific Research
Vocal fold cysts are benign lesions of the larynx and affect both children and adults. The vocal fold cysts can be classified into two types such as mucous retention cysts and epidermoid cysts.
Santosh Kumar Swain
doaj   +1 more source

Fruquintinib Plus TAS‐102 With or Without SBRT as Third‐ Or Later‐Line Therapy for Metastatic Colorectal Cancer: Preliminary Results From a Prospective Phase II Trial

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Both fruquintinib and TAS‐102 monotherapies are guideline‐recommended for third‐line treatment of metastatic colorectal cancer (mCRC). This study aimed to analyze the preliminary outcomes of fruquintinib combined with TAS‐102, with or without stereotactic body radiation therapy (SBRT), as a third‐ or later‐line therapy for mCRC.
Yi Wang   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy